GlobeNewswire

OneMedNet Reports Preliminary Revenue for Third Quarter 2026 and Fourth Quarter 2026 Outlook
06/11/2026
MINNEAPOLIS, Nov. 06, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet,” the “Company,” “we,” “us” or “our”), a leading provider of First-Party (Direct-from-Source) regulatory decision-grade, AI [...]
Notification of managers’ transactions
06/11/2026
ANNOUNCEMENT NO. 327 6 November 2026 ChemoMetec A/S has received the enclosed notification pursuant to Article 19 of EU Regulation No. 596/2014 concerning transactions in shares of ChemoMetec A/S carried out by persons [...]
New phase 2 data highlight the strength of the immune response induced by personalized cancer vaccine EVX-01
06/11/2026
Detection of neoantigen-specific T cells directly ex vivo indicates strong EVX-01-induced immune responses Data further underlines the strong predictive performance of Evaxion’s AI-Immunology™ platform The new biomarker [...]
HCW Biologics’ Presentation for HCW11-040 Recognized for Scientific Rigor, Novelty, Clarity and Potential Impact on Cancer Immunotherapy by the Society for Immunotherapy of Cancer
06/11/2026
Designated as one of the Top 150 abstracts submitted for the 41 st Annual Meeting of the Society for Immunotherapy of Cancer HCW11-040 is a first-in-class, second-generation, tetravalent pembrolizumab (Keytruda®) based [...]
Le KFSH de Riyad obtient la distinction « Global Elite Five-Star » de Davos Healthcare et figure parmi les 5 % des hôpitaux les mieux évalués au monde
06/11/2026
RIYAD, Arabie saoudite, 06 nov. 2026 (GLOBE NEWSWIRE) -- Le King Faisal Specialist Hospital & Research Centre (KFSH) de Riyad s’est vu décerner la médaille « Global Elite Five-Star » par Davos Healthcare, la plus [...]
TOMI Environmental Solutions, Inc. Reschedules Third Quarter 2026 Earnings Call to Thursday, November 12
06/11/2026
FREDERICK, Md., Nov. 06, 2026 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc. (NASDAQ: TOMZ), a global leader in disinfection and decontamination solutions, today announced it will reschedule its conference call [...]
CG Oncology Reports Third Quarter 2026 Financial Results and Provides Business Updates
06/11/2026
PIVOT-006 Phase 3 topline data evaluating cretostimogene monotherapy as an adjuvant therapy in intermediate-risk and high-grade Ta NMIBC anticipated November 2026 BOND-003 Cohort P and CORE-008 Cohort CX 12-month data [...]
Integra LifeSciences to Present at the 2026 UBS Global Healthcare Conference
06/11/2026
PRINCETON, N.J., Nov. 06, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today announced that Lea Knight, chief financial officer, will [...]
Protara Therapeutics Announces Third Quarter 2026 Financial Results and Provides a Business Update
06/11/2026
Expect to complete enrollment of the BCG-Unresponsive registrational cohort of the ADVANCED-2 trial of TARA-002 in NMIBC by year-end 2026 Enrollment in registrational STARBORN-1 trial now expected to complete in early [...]
Curonix Freedom® Peripheral Nerve Stimulator (PNS) System Named Top New Pain Management Technology in Orthopedics This Week's Inaugural 2026 Awards
06/11/2026
POMPANO BEACH, Fla., Nov. 06, 2026 (GLOBE NEWSWIRE) -- Curonix, a leading medical technology company dedicated to relieving chronic pain, today announced that the Freedom® Peripheral Nerve Stimulator (PNS) System has [...]
Once-Weekly TransCon® CNP (Navepegritide) to Receive 10 Years of Market Exclusivity Upon Approval in the European Union
06/11/2026
– Final European Commission decision expected during Q4 2026 COPENHAGEN, Denmark, Nov. 06, 2026 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that the Committee for Orphan Medicinal Products ( [...]
Aligos Therapeutics Reports Recent Business Progress and Third Quarter 2026 Financial Results
06/11/2026
SOUTH SAN FRANCISCO, Calif., Nov. 06, 2026 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”), a clinical stage biotechnology company focused on improving patient outcomes through best-in-class [...]
MIMEDX to Participate in Upcoming Investor Conferences
06/11/2026
MARIETTA, Ga., Nov. 06, 2026 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that members of its senior management will participate in the following investor conferences [...]
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
06/11/2026
DALLAS, Nov. 06, 2026 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies [...]
Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
06/11/2026
RADNOR, Pa., Nov. 06, 2026 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a biopharmaceutical company focused on developing medicines to target hypertension and aldosterone-related adverse outcomes in [...]
Regenerative Ophthalmology Takes Center Stage This November 7 at the Next Generation Medicine Congress 2026 in Dubai
06/11/2026
DUBAI, United Arab Emirates, Nov. 06, 2026 (GLOBE NEWSWIRE) -- As the globe moves to the era of cellular restoration in healthcare, Next Generation Medicine Congress 2026 decided to dedicate November 7–10, 2026, to four [...]
Notice of Annual General Meeting 2026
06/11/2026
The Annual General Meeting of Coloplast A/S will be held on Tuesday, 1 December 2026 at 3:30 pm CET at the premises of Coloplast A/S, Holtedam 3 (the Aage Louis-Hansen Auditorium), Humlebæk, Denmark. The notice of the [...]
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06/11/2026
SAN DIEGO, Nov. 06, 2026 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (the “Company”) (Nasdaq: KURA), a biopharmaceutical company focused on precision medicines for the treatment of cancer, today announced that on November 2 [...]
InflaRx Announces Publication of Phase 1 Data Demonstrating Favorable Safety and Pharmacokinetic/Pharmacodynamic Profile of Izicopan
06/11/2026
Izicopan achieved rapid and sustained inhibition of C5a/C5aR1 signaling Pharmacokinetic results demonstrated dose-dependent exposure, with izicopan well tolerated across all single and multiple doses evaluated Findings [...]

Pages

Other news

Test 2

Lorem ipsum

Test 1

Lorem upsum